Mitochondrial traits are features linked to how mitochondria make energy, communicate with the rest of a cell, and pass mitochondrial DNA from one generation to the next. Mitochondria produce most cellular ATP, carry a 37-gene genome, and are usually inherited from the mother. Research is active, but many longevity claims remain unproven in humans. 1
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →What are mitochondrial traits?
Mitochondrial traits are the measurable features of mitochondria: their number, shape, energy output, DNA, and response to stress. These traits can differ among tissues and can change with age, illness, activity, and inherited genetic variants. 1
Mitochondria are often called the cell’s power plants. Through oxidative phosphorylation, the electron transport chain uses oxygen and nutrients to help make adenosine triphosphate, or ATP. ATP is the usable chemical energy that supports movement, nerve signaling, heartbeats, and many other cellular jobs. 1
Energy production is only one part of the picture. Mitochondria also take part in cell signaling, stress responses, reactive oxygen species signaling, calcium handling, changes in cell shape, and apoptosis, a controlled form of cell death. These roles help explain why mitochondrial problems can affect more than fatigue alone. 1
What are the key facts about mitochondrial traits?
The most useful starting point is that mitochondria are both energy-producing structures and genetic structures. Humans have 37 mtDNA genes, but mitochondrial function also depends on many genes in nuclear DNA. 1
Mitochondria make most of the cell’s usable energy
NIH describes mitochondria as producing about 90% of the energy cells need. Cells with high energy demand, including muscle cells, neurons, and liver cells, may contain hundreds or thousands of mitochondria. 1
Mitochondria have their own DNA
Mitochondrial DNA is separate from the DNA packed into chromosomes in the cell nucleus. Thirteen mtDNA genes help make parts of the oxidative-phosphorylation system; the remaining genes make transfer and ribosomal RNAs needed to build proteins. 1
Mitochondrial DNA is usually inherited from the mother
Maternal inheritance means mothers typically pass mtDNA to all of their children, while fathers generally do not pass their mtDNA on. This pattern applies to mtDNA variants, not to every condition involving mitochondrial function, because nuclear-DNA variants can follow other inheritance patterns. 1 For a closer look, see our guide to why mitochondrial DNA is usually maternal.
High-energy tissues are often most affected when mitochondria fail
When inherited mitochondrial disease disrupts energy production, organs with high energy needs may be affected first or most severely. Muscle and nervous-system symptoms are common, but heart, liver, hearing, vision, and endocrine effects can also occur. 2
Mitochondrial biomarkers are not the same as proven lifespan effects
Researchers study biomarkers such as mtDNA copy number, oxidative stress markers, and measures of mitochondrial respiration. A biomarker association is not proof of longer life: a blood measurement can reflect many factors and does not establish that changing it will prevent disease or extend lifespan. 8
How do mitochondria affect energy, aging, and everyday health?
Mitochondria affect everyday health because nearly every cell needs ATP and uses mitochondrial signals. Mitochondrial dynamics—the ongoing splitting, joining, movement, and replacement of mitochondria—help cells adapt to changing energy demands. 1
Mitochondrial biogenesis means making new mitochondria. Exercise and other metabolic stresses can influence these pathways, but that does not mean a person can measure or “upgrade” their mitochondria with a consumer test or supplement. Human studies are still working out which measures are clinically meaningful. 1
In human observational research, mitochondrial dysfunction has been linked with diabetes, heart and liver disease, dementia, Parkinson’s disease, and aging. These links are important research clues, but they do not show that mitochondrial changes alone cause each condition or that a mitochondrial product can treat it. 1
| Evidence type | What it can tell us | What it cannot prove |
|---|---|---|
| Human clinical studies | Whether a defined intervention changed a defined health outcome in participants | That results apply to every product, dose, population, or compounded formulation |
| Human observational studies | Whether mitochondrial measures and health outcomes occur together | That one finding caused the other |
| Animal studies | Mechanisms and early safety or efficacy signals | Human lifespan benefit or a safe human treatment |
| Cell studies | How pathways may work inside cells | Whole-body health outcomes in people |
Which mitochondrial traits are genetic?
Both mitochondrial DNA and nuclear DNA shape mitochondrial function. Most mitochondrial proteins are encoded by nuclear DNA, while mtDNA supplies a small but essential set of genes involved in energy production. 1
A person can have a pathogenic variant in mtDNA, in nuclear DNA, or in both. Nuclear variants can be inherited in autosomal dominant, autosomal recessive, or X-linked patterns. That is why a family history does not always show the classic maternal pattern. 2
Another important trait is heteroplasmy: a mixture of different mtDNA versions within the same person or tissue. Heteroplasmy can vary by tissue, which can help explain why relatives with the same mtDNA variant may have different symptoms and why blood testing may not answer every diagnostic question. 2
If you are sorting through test results, our overview of mitochondrial genetic testing explains what testing can and cannot clarify. A genetics professional can help decide whether testing fits your symptoms and family history. 3
What symptoms can happen when mitochondrial function is impaired?
Symptoms of mitochondrial disease can involve one organ or several, and they range from mild to serious. Fatigue alone is common and has many possible causes, so it cannot diagnose a mitochondrial disorder. 2
- Muscle fatigue, exercise intolerance, muscle weakness, cramps, or drooping eyelids may occur when muscle energy production is affected. 2
- Neurologic symptoms can include seizures, migraine-like episodes, balance problems, developmental differences, or neuropathy. Vision loss and hearing loss can also occur in some mitochondrial conditions. 2
- Heart involvement may include cardiomyopathy or rhythm problems. Liver involvement, diabetes, and digestive symptoms can occur in particular disorders. 2
- Urgent symptoms such as chest pain, fainting, new severe weakness, seizure, sudden vision change, or trouble breathing need prompt medical care. 3
What is the most common mitochondrial disorder?
There is no single simple answer because rare mitochondrial disorders are diverse and are counted differently across studies. Some conditions arise from mtDNA variants, while many others come from nuclear-DNA variants that affect mitochondrial function. 2
Named disorders researchers often study include MELAS, MERRF, Leigh syndrome, mitochondrial encephalomyopathy, and disorders caused by variants in nuclear genes. Diagnosis usually combines clinical history, laboratory testing, genetic testing, and sometimes specialist imaging or tissue studies. 2 Our guide to mitochondrial mutations covers why a genetic change does not always predict symptoms by itself.
How can someone support mitochondrial health?
The most evidence-based approach is to support whole-body health and manage diagnosed conditions rather than chase a “mitochondrial booster.” Regular physical activity, adequate sleep, balanced nutrition, and avoiding tobacco support general cardiometabolic health, though they are not cures for mitochondrial disease. 3
For a person with confirmed mitochondrial disease, care should be individualized. Specialists may address nutrition, activity limits, heart screening, hearing or vision needs, diabetes, medication risks, and genetic counseling based on the specific disorder. 3
Be cautious with online products that promise to repair mitochondria, reverse aging, or restore energy. Those promises go beyond current human evidence. Our evidence-focused guide to improving mitochondrial health explains what is established and what remains experimental.
3-min quiz
Talk through your longevity goals with a licensed provider
Chia offers clinician-reviewed longevity care for appropriate patients, including NAD+, glutathione, and sermorelin. A licensed US provider reviews your health information; prescriptions require a medical evaluation and are not guaranteed. Medications are compounded by state-licensed US 503A pharmacies and shipped to your door. Compounded drugs are not FDA-approved.
What does the evidence say about mitochondrial health and longevity?
Human research supports the importance of mitochondria in health, but no mitochondrial biomarker has been proven to predict an individual’s lifespan. Human clinical evidence has not shown that changing a mitochondrial marker with a supplement, peptide, or infusion extends human life. 1
Human observational studies can identify patterns worth studying. For example, blood mtDNA copy number has been associated with health and mortality measures in some cohorts. Associations may reflect illness, activity, inflammation, medication use, or other factors; they cannot establish cause and effect. 8
Animal and cell research is useful for studying reactive oxygen species, mitochondrial dynamics, and possible treatment targets. Still, an animal or cell result is not a lifespan promise for people. Translating a mechanism into a safe, effective human treatment requires well-designed clinical trials. 1 7
How does Chia approach mitochondrial health support?
At Chia, we do not present longevity treatments as therapies for mitochondrial disease or as proven ways to extend human lifespan. Our role is clinician-guided longevity care, including discussion of goals, health history, possible risks, and evidence limits—not diagnosis or treatment of a suspected genetic mitochondrial condition. 3
Chia offers NAD+ as an injection, with plans currently starting at $179 per month, or a nasal spray, with plans currently starting at $119 per month. NAD+ is a molecule involved in cellular energy metabolism, but available human evidence does not establish that NAD+ treatment repairs mitochondrial disease or extends lifespan. 1
We also offer glutathione as an injection or nasal spray, with plans currently starting at $179 per month. Glutathione is part of the body’s antioxidant systems, but antioxidant biology is complex, and glutathione treatment is not proven to treat mitochondrial disease or extend human lifespan. 1
For patients whose clinician determines it is appropriate, Foundation Longevity combines sermorelin injection, NAD+ injection, and glutathione injection; plans currently start at $399 per month. Sermorelin is not offered by Chia as a treatment for mitochondrial disease, and combination-specific evidence for mitochondrial outcomes or longevity is not established. 7
| Chia option | Available form | What to know |
|---|---|---|
| NAD+ | Injection; nasal spray | Offered for clinician-reviewed longevity care, not as a proven mitochondrial-disease treatment or lifespan therapy. 1 |
| Glutathione | Injection; nasal spray | Part of antioxidant biology; not proven to repair mitochondrial disease or extend human lifespan. 1 |
| Sermorelin | Injection; nasal spray; tablets | Included in Foundation Longevity only as an injection; mitochondrial-disease and lifespan outcomes are not established. 7 |
| Foundation Longevity | Sermorelin injection + NAD+ injection + glutathione injection | A multi-treatment protocol that requires clinician review; it is not a mitochondrial-disease treatment. 7 |
Care at Chia is 100% online. You complete a health questionnaire, then a licensed US provider reviews it and prescribes only where clinically appropriate. Dosing is provider-guided, patients can message their care team through the portal, and medication is compounded by a state-licensed US 503A pharmacy and shipped to the patient’s door.
How are mitochondrial diseases being studied and treated?
Mitochondrial-disease trials are difficult because these conditions are rare, genetically diverse, and variable over time. Natural-history studies—which track how disease changes without testing a new treatment—help researchers choose meaningful outcomes and design stronger future trials. 4 5
Researchers also face regulatory challenges: a treatment needs reliable safety data and evidence of a meaningful patient benefit, not only a shift in a laboratory marker. Reviews of rare mitochondrial-disease development stress the need for better outcome measures and carefully designed studies. 6 7
If you suspect a mitochondrial disorder, avoid self-directed treatment based on a social-media symptom list or a direct-to-consumer biomarker. A clinician or genetics specialist can help rule out more common causes and determine whether targeted evaluation is appropriate. 3
Support overall health with regular activity, adequate sleep, balanced nutrition, and care for conditions such as diabetes or heart disease. These steps support general health but do not cure mitochondrial disease. 3 If symptoms are persistent or affect several body systems, seek clinical evaluation. 3
Not reliably. Measures such as mtDNA copy number may be associated with health outcomes in research, but they cannot predict one person’s lifespan or prove that changing the measure will extend life. 8
3-min quiz
Start with a clinician-reviewed online visit
If you want to discuss energy, healthy aging, or whether Chia’s NAD+, glutathione, or Foundation Longevity options fit your goals, start with an online health questionnaire. A licensed US provider reviews eligibility, and a prescription is not guaranteed. Compounded medications are not FDA-approved and are not presented as treatments for mitochondrial disease.
References
- 1.National Institutes of Health. Mitochondria and health. NIH Research in Context, 2025.
- 2.Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nature Reviews Disease Primers, 2016.
- 3.Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine, 2015.
- 4.Stenton SL, Prokisch H, et al. Moving towards clinical trials for mitochondrial diseases. Journal of Inherited Metabolic Disease, 2021.
- 5.ClinicalTrials.gov. The Natural History of Mitochondrial Diseases, NCT06504433. U.S. National Library of Medicine, 2024.
- 6.Pfeffer G, Horvath R, Klopstock T, et al. New treatments for mitochondrial disease—no time to drop our standards. Nature Reviews Neurology, 2013.
- 7.Khan NA, Govindaraj P, Meena AK, Thangaraj K. Mitochondrial disorders: challenges in therapeutic development and regulatory pathways. Frontiers in Neurology, 2022.
- 8.National Institute on Aging. Personality and mortality linked to number of mitochondrial DNA molecules in blood. NIH Research Highlight, 2021.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.


